4American Diabetes Association. Standards of medical care in diabetes--2014 [J]. Diabetes Care, 2014,37 Suppl 1 :S14-80.
5Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis [J]. Lancet, 2012,3880(9854) : 1662-1673.
6Abougalambou SS, Abougalambou AS. Prevalence and risk factors of mieroalbuminuria in type 2 diabetes mellitus outpatients at University Sains Malaysia Hospital [J]. DiabetesMetab Syndr, 2013,7(2) :64-67.
7Ruggenenti P, Porrini EL, Gaspari F, et al. Glomerular hyperfihration and renal disease progression in type 2 diabetes [J ]. Diabetes Care, 2012,35 (10) : 2061-2068.
8Hovind P, Rossing P, Johnson R J, et al. Serum uric acid as a new player in the development of diabetic nephropathy [J]. J Ren Nutr, 2011,21(1):124-127.
9Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function [J]. Diabetes Care, 2012,35(1) : 99-104.
10Okada H, Fukui M, Tanaka M, et al. Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephrgpathy in patients with type 2 diabetes [J]. Diabetes Care, 2013,36(7) : 1908-1912.
